NCT04979650View on ClinicalTrials.gov

Corticosteroid Effects on Asymptomatic Gadolinium-enhancing Lesions in Multiple Sclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

May 22, 2021

Primary Completion Date

December 28, 2023

Study Completion Date

December 29, 2023

Conditions
Multiple Sclerosis, Relapsing-RemittingMagnetic Resonance ImagingMethylprednisolone
Interventions
DRUG

Methylprednisolone succinate

1 gram of methylprednisolone succinate within 500 ccs of normal saline

DRUG

Normal saline

500 g of normal saline without methylprednisolone succinate

Trial Locations (1)

4815838477

Mazandaran University of medical sciences, Sari

All Listed Sponsors
lead

Mazandaran University of Medical Sciences

OTHER